Ilika PLC 2024 AR2
The report outlines Ilika's operational and financial progress for the fiscal year ended April 30, 2024, focusing on the development of its solid-state battery technologies, Stereax and Goliath. Key achievements include a 10-year licensing agreement with Cirtec Medical for Stereax manufacturing and reaching the D4 design freeze milestone for Goliath. On the sustainability front, the company refreshed its materiality matrix, maintained its ISO 9001 and ISO 14001 certifications, and achieved a 96% completion rate on its ESG Framework. Financially, Ilika reported a total income of £2.6m and reduced its adjusted EBITDA loss to £4.1m.
Company: Ilika PLC
Sector: Professional & technical services
Country: United Kingdom
Year: 2024
Type: AR2
Pages: 76
Ilika PLC
The report outlines Ilika's operational and financial progress for the fiscal year ended April 30, 2024, focusing on the development of its solid-state battery technologies, Stereax and Goliath. Key achievements include a 10-year licensing agreement with Cirtec Medical for Stereax manufacturing and reaching the D4 design freeze milestone for Goliath. On the sustainability front, the company refreshed its materiality matrix, maintained its ISO 9001 and ISO 14001 certifications, and achieved a 96% completion rate on its ESG Framework. Financially, Ilika reported a total income of £2.6m and reduced its adjusted EBITDA loss to £4.1m.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
May 1, 2023 - Apr 30, 2024
Fiscal Year
2024
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
Assurance
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Women on Board
Employees